AcelRX Pharmaceuticals Quote - ACRX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.86

Bid

0.861

Ask

0.89

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

14.579M

Previous Close

0.86

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

16,952,000

Dividend Yield

PE Ratio

-0.79

Earnings Per Share (EPS)

-1.09

Revenue

651k

Net Profit

-18.4M

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

talphera.com

Headquarters

Wilmington, Delaware, USA

Founded

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ACRX - Frequently Asked Questions (FAQ)

What is the current AcelRX Pharmaceuticals share price?

The current share price of AcelRX Pharmaceuticals is US$ 0.86

How many AcelRX Pharmaceuticals shares are in issue?

AcelRX Pharmaceuticals has 16,952,000 shares in issue

What is the market cap of AcelRX Pharmaceuticals?

The market capitalisation of AcelRX Pharmaceuticals is USD 14.58M

What is the 1 year trading range for AcelRX Pharmaceuticals share price?

AcelRX Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of AcelRX Pharmaceuticals?

The price to earnings ratio of AcelRX Pharmaceuticals is -0.79

What is the cash to sales ratio of AcelRX Pharmaceuticals?

The cash to sales ratio of AcelRX Pharmaceuticals is 22.4

What is the reporting currency for AcelRX Pharmaceuticals?

AcelRX Pharmaceuticals reports financial results in USD

What is the latest annual turnover for AcelRX Pharmaceuticals?

The latest annual turnover of AcelRX Pharmaceuticals is USD 651k

What is the latest annual profit for AcelRX Pharmaceuticals?

The latest annual profit of AcelRX Pharmaceuticals is USD -18.4M

What is the registered address of AcelRX Pharmaceuticals?

The registered address for AcelRX Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the AcelRX Pharmaceuticals website address?

The website address for AcelRX Pharmaceuticals is talphera.com

Which industry sector does AcelRX Pharmaceuticals operate in?

AcelRX Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
CAPSCapstone Holding Corp	US$ 3.4999 (1,299.96%)	51.66k
STSSSharps Technology Inc	US$ 0.6663 (124.57%)	448.37M
RDFNRedfin Corporation	US$ 9.835 (68.99%)	66.08M
MLYSMineralys Therapeutics Inc	US$ 17.71 (68.35%)	10.44M
CKPTCheckpoint Therapeutics Inc	US$ 4.035 (63.36%)	41.84M
JVACoffee Holdings Co	US$ 6.343 (-33.72%)	701.79k
SXTCChina SXT Pharmaceuticals Inc	US$ 2.95 (-31.60%)	125.71k
DSYBig Tree Cloud Holdings Limited	US$ 1.20 (-30.64%)	449.12k
ALBTAvalon GloboCare Corporation	US$ 5.19 (-28.22%)	139.64k
MNDRMobile health Network Solutions	US$ 2.08 (-27.80%)	270.43k
STSSSharps Technology Inc	US$ 0.6663 (124.57%)	448.37M
NVDANVIDIA Corporation	US$ 108.1088 (-4.07%)	175.15M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8.3796 (-21.39%)	131.9M
SPRCSciSparc Ltd	US$ 0.3897 (21.93%)	102.25M
ICONIcon Energy Corporation	US$ 0.1478 (-12.44%)	96.14M

Symbol

Price

Vol.